Short Interest in TRxADE HEALTH, Inc. (NASDAQ:MEDS) Decreases By 31.0%

TRxADE HEALTH, Inc. (NASDAQ:MEDS) was the target of a significant decrease in short interest in the month of June. As of June 15th, there was short interest totalling 6,900 shares, a decrease of 31.0% from the May 31st total of 10,000 shares. Approximately 1.4% of the company’s shares are sold short. Based on an average daily trading volume, of 97,200 shares, the short-interest ratio is presently 0.1 days.

TRxADE HEALTH Stock Performance

Shares of MEDS traded down $1.99 on Friday, hitting $11.17. 175,920 shares of the stock traded hands, compared to its average volume of 263,833. The stock’s 50 day moving average is $6.95 and its two-hundred day moving average is $8.15. TRxADE HEALTH has a 1 year low of $3.69 and a 1 year high of $44.56.

Hedge Funds Weigh In On TRxADE HEALTH

An institutional investor recently bought a new position in TRxADE HEALTH stock. Virtu Financial LLC acquired a new stake in shares of TRxADE HEALTH, Inc. (NASDAQ:MEDS) during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 10,617 shares of the company’s stock, valued at approximately $109,000. Virtu Financial LLC owned about 0.75% of TRxADE HEALTH at the end of the most recent reporting period. Hedge funds and other institutional investors own 5.68% of the company’s stock.

About TRxADE HEALTH

TRxADE HEALTH, Inc operates as a health services information technology (IT) company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement; and designs, develops, owns, and operates a business-to-business web-based marketplace.